| 18472150
|
Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. |
J Allergy Clin Immunol |
2008 |
Davoine F;Cao M;Wu Y;Ajamian F;Ilarraza R;Kokaji AI;Moqbel R;Adamko DJ |
View
More |
| 19596142
|
Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. |
J Allergy Clin Immunol |
2009 |
DeMore JP;Weisshaar EH;Vrtis RF;Swenson CA;Evans MD;Morin A;Hazel E;Bork JA;Kakumanu S;Sorkness R;Busse WW;Gern JE |
View
More |
| 22331068
|
Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. |
J Immunol |
2012 |
Schneider D;Hong JY;Popova AP;Bowman ER;Linn MJ;McLean AM;Zhao Y;Sonstein J;Bentley JK;Weinberg JB;Lukacs NW;Curtis JL;Sajjan US;Hershenson MB |
View
More |
| 22611238
|
Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mechanism with relevance to asthma. |
J Immunol |
2012 |
Pritchard AL;Carroll ML;Burel JG;White OJ;Phipps S;Upham JW |
View
More |
| 28705625
|
Antiviral activity of gemcitabine against human rhinovirus in vitro and in vivo. |
Antiviral Res |
2017 |
Song JH;Kim SR;Heo EY;Lee JY;Kim DE;Cho S;Chang SY;Yoon BI;Seong J;Ko HJ |
View
More |
